Laboratorios Hipra, S.A.
1 clinical trials · Sponsor
◉ Watch Laboratorios Hipra, S.A.
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19) (NCT05007509) | Laboratorios Hipra, S.A. | 2021-08-16 |
Track Laboratorios Hipra, S.A. automatically
Every clearance here is in the API, with alerts when new ones post.